Exero Medical Appoints Prominent Gastrointestinal Expert Professor Charles Knowles to its Scientific Advisory Board

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

Exero Medical, developer of a biodegradable wireless sensor for early detection of anastomotic leaks (AL) following GI surgery, today announced the appointment of Charles Knowles, Professor of Surgery at Queen Mary University of London and Consultant Colorectal Surgeon at Barts Health NHS Trust, to its scientific advisory board.

“We are excited to welcome Professor Charles Knowles, whose clinical expertise and deep knowledge of the gastrointestinal field brings immediate value to Exero Medical, and will be instrumental in navigating both clinical trials and clinical implementation of our AL detection technology,” said Erez Shor, PhD, CEO of Exero Medical. “Professor Knowles provides us with an axis between the operation and functionality of our leak detection system and its clinical application. His expert input will be vital in the development of our technology, which will result in better, safer care of GI surgery patients.”

Professor Knowles has been a major contributor to the field of gastrointestinal research for over 25 years. Professor Knowles is Deputy Director of the Blizard Institute and Honorary Professor of Experimental Therapeutics at UCL. He is Chair of several research committees including the European Society of Coloproctology. Professor Knowles has authored over 190 peer reviewed publications as well as contributed several book chapters to major international colorectal and general surgical texts.

“AL has a 6-10% occurrence rate post-operation in lower GI procedures and can lead to life threatening complications, with substantial risk of mortality,” said Professor Knowles. “I look forward to working closely with the Exero Medical team, whose technology is novel to this field, to address this widespread issue and help alert physicians to post-operative AL early on, allowing for timely medical intervention and improved patient outcomes.”



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.